Valerie R. Wiersma

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Editorial: Unlocking autophagy's full potential: embracing a multidimensional approach for targeted cancer treatment.

Editorial: Unlocking autophagy's full potential: embracing a multidimensional approach for targeted cancer treatment.

Journal: Frontiers in pharmacology

Published: February 17, 2026

Toward designer magic bullets: Epigenetic editing to empower CAR T cells.

Toward designer magic bullets: Epigenetic editing to empower CAR T cells.

Journal: Molecular therapy. Nucleic acids

Published: December 30, 2025

Epigenetic editing to advance CAR T cell therapy.

Epigenetic editing to advance CAR T cell therapy.

Journal: Clinical epigenetics

Published: November 02, 2025

Finding the Sweet Spot for the Treatment of B Cell Malignancies.

Finding the Sweet Spot for the Treatment of B Cell Malignancies.

Journal: Cancers

Published: July 05, 2025

Real-World Accuracy of Continuous Glucose Monitoring During Intensive Hematological Care: A Prospective Study.

Real-World Accuracy of Continuous Glucose Monitoring During Intensive Hematological Care: A Prospective Study.

Journal: Diabetes technology & therapeutics

Published: July 02, 2025

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.

Journal: Frontiers in pharmacology

Published: March 27, 2025

High Frequency of Severe Hyperglycemia Observed During Intensive Hematologic Care: A Prospective Study Using Continuous Glucose Monitoring.

High Frequency of Severe Hyperglycemia Observed During Intensive Hematologic Care: A Prospective Study Using Continuous Glucose Monitoring.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: June 12, 2024

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.

Journal: Experimental hematology & oncology

Published: January 25, 2024

Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity.

Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity.

Journal: Frontiers in immunology

Published: September 01, 2023

COPD Patients Display Increased Peripheral Blood Somatic Mutations Which Associate With the Prevalence of Co-morbidities.

COPD Patients Display Increased Peripheral Blood Somatic Mutations Which Associate With the Prevalence of Co-morbidities.

Journal: Archivos de bronconeumologia

Published: July 28, 2023

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells.

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells.

Journal: Frontiers in immunology

Published: March 22, 2023

Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance.

Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance.

Journal: Cell death discovery

Published: March 14, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026